Table 2.
Clinical and Demographic Parameters of Invasive Listeriosis in ESKD Patients
| Variable | Total (N=26) | In-hospital Survive (N=14) | In-hospital Death (N=12) | Odds Ratio (95% CI) | p-value |
|---|---|---|---|---|---|
| No. (%) | |||||
| Age (years) (medium, 25–75% tile) | 58.75 (44.13–76.03) | 60.85 (37.88–74.78) | 57.20 (50.35–76.20) | 1.00 (0.96–1.05) | 0.898 |
| Gender (No. males/females) | 10/16 | 3/11 | 7/5 | 5.13 (0.99–32.87) | 0.105 |
| Smoking | 6 (23) | 1 (7) | 5 (24) | 9.29 (1.19–197.54) | 0.065 |
| Comorbidities | |||||
| Diabetes mellitus | 8 (31) | 4 (29) | 4 (33) | 1.25 (0.23–6.91) | 1.000 |
| Hypertension | 16 (62) | 9 (64) | 7 (58) | 0.78 (0.15–3.86) | 1.000 |
| Coronary artery disease | 2 (8) | 0 (0) | 2 (17) | N/A | 0.203 |
| Heart failure | 7 (27) | 2 (14) | 5 (42) | 4.29 (0.71–36.03) | 0.190 |
| Atrial fibrillation | 1 (4) | 0 (0) | 1 (8) | N/A | 0.462 |
| Cirrhosis | 4 (15) | 1 (7) | 3 (25) | 4.33 (0.47–95.76) | 0.306 |
| Peptic ulcer disease | 10 (38) | 3 (21) | 7 (58) | 5.13 (0.99–32.87) | 0.105 |
| Cerebral vascular accident | 5 (19) | 3 (21) | 2 (17) | 0.73 (0.08–5.33) | 1.000 |
| COPD | 1 (4) | 0 (0) | 1 (8) | N/A | 0.462 |
| Solid cancer | 6 (23) | 4 (29) | 2 (17) | 0.50 (0.06–3.19) | 0.652 |
| Hematologic malignancy | 3 (12) | 1 (7) | 2 (17) | 2.60 (0.22–60.78) | 0.580 |
| Autoimmune diseases | 11 (42) | 6 (43) | 5 (42) | 0.95 (0.19–4.60) | 1.000 |
| Immunosuppressants use | 13 (50) | 7 (50) | 6 (50) | 1.00 (0.21–4.77) | 1.000 |
| Anti-cancer therapy | |||||
| Chemotherapy in prior 4 weeks | 3 (12) | 1 (7) | 2 (17) | 2.60 (0.22–60.78) | 0.580 |
| Radiotherapy in prior 4 weeks | 2 (8) | 1 (7) | 1 (8) | 1.18 (0.04–32.29) | 1.000 |
| Modality of RRT | |||||
| HD/PD | 23/3 | 11/3 | 12/0 | N/A | 0.056 |
Abbreviations: CI, confidence interval; SD, standard deviation; COPD, chronic obstructive pulmonary disease; RRT, renal replacement therapy; HD, hemodialysis; PD, peritoneal dialysis; N/A, not applicable.